Cargando…
The histone deacetylase inhibiting drug Entinostat induces lipid accumulation in differentiated HepaRG cells
Dietary overload of toxic, free metabolic intermediates leads to disrupted insulin signalling and fatty liver disease. However, it was recently reported that this pathway might not be universal: depletion of histone deacetylase (HDAC) enhances insulin sensitivity alongside hepatic lipid accumulation...
Autores principales: | Nunn, Abigail D. G., Scopigno, Tullio, Pediconi, Natalia, Levrero, Massimo, Hagman, Henning, Kiskis, Juris, Enejder, Annika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913258/ https://www.ncbi.nlm.nih.gov/pubmed/27320682 http://dx.doi.org/10.1038/srep28025 |
Ejemplares similares
-
Erratum: The histone deacetylase inhibiting drug Entinostat induces lipid accumulation in differentiated HepaRG cells
por: Nunn, Abigail D. G., et al.
Publicado: (2016) -
Evaluation of the impact of matrix stiffness on encapsulated HepaRG spheroids
por: Rebelo, Sofia P, et al.
Publicado: (2013) -
Evaluation of a novel PXR‐knockout in HepaRG(™) cells
por: Williamson, Beth, et al.
Publicado: (2016) -
Active Transport of Hepatotoxic Pyrrolizidine Alkaloids in HepaRG Cells
por: Enge, Anne-Margarethe, et al.
Publicado: (2021) -
Transcriptional and Epigenetic Consequences of DMSO Treatment on HepaRG Cells
por: Dubois-Pot-Schneider, Hélène, et al.
Publicado: (2022)